Protagonist Therapeutics Inc (PTGX)
R&D to Revenue
19.70%
Quarterly · Period ending:
PTGX R&D to Revenue
Latest reported19.70%period ending
Latest reported19.70%period ending
PTGX Quarterly R&D/Revenue (0.00% → 19.70%)
Latest values, visible window
High-resolution chart · PNG
PTGX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 19.703% | |
| 82.9176% | |
| 623.3427% | |
| 848.9601% | |
| 667.7966% | |
| 126.7363% | |
| 20.455% | |
| 769.4118% | |
| 804.4156% | |
| 13.2315% | |
| 48.165% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 4,029.22% | |
| 141.1943% | |
| 455.7619% | |
| 359.2845% | |
| 1,210.4636% | |
| 405.122% | |
| 356.2124% | |
| 121.9689% | |
| 325.8324% | |
| 514.6148% | |
| 585.1784% | |
| 417.6044% | |
| -236.3536% | |
| 797.6923% | |
| 605.5249% | |
| 198.545% | |
| 151.9188% | |
| 142.5471% | |
| 103.9177% | |
| 127.1837% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |